On May 10, 2019, Teva launched a generic version of Allergan's Delzicol (mesalamine) delayed- release capsules. Delzicol is approved for the treatment of mildly to moderately active ulcerative colitis in patients 5 years of age and older, and for the maintenance of remission of ulcerative colitis in adults.

When is mesalamine going generic?

On November 27, 2019, Mylan launched an AB-rated generic version of Bausch Health Apriso (mesalamine) 375 mg extended-release capsules. Apriso is approved for the maintenance of remission of ulcerative colitis in patients 18 years of age and older.

Is there a substitute for mesalamine?

The suggested alternatives Lialda, Apriso, and Pentasa all contain the same active ingredient as Asacol HD (mesalamine).